Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03094273 · ClinicalTrials.gov registry record
Prospective Study of 2 mm Margins for the Biopsy of Dysplastic Nevi
A clinical trial, sponsored by NYU Langone Health.
- Completed
- Registry status
- 138
- Enrollment target
NCT03094273: Completed study, sponsored by NYU Langone Health.
NCT03094273 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 138 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03094273 has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 138 participants
- Enrollment target
Study Summary
Non-interventional study to evaluate the utility of removing Dysplastic Nevi with a defined 2 mm margin.
Primary Outcome
2 mm saucerization biopsy
Interventions
- PROCEDURE Saucerization biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 138 participants |
| Start Date | 2013-02-25 |
| Est. Completion | 2016-03 |
What the finished NCT03094273 record still lists
NCT03094273 is an observational study that tracks outcomes without assigning an intervention. The registered 138 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Saucerization biopsy is the first listed.
NCT03094273 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03094273 about?
NCT03094273 is a clinical study titled "Prospective Study of 2 mm Margins for the Biopsy of Dysplastic Nevi". Non-interventional study to evaluate the utility of removing Dysplastic Nevi with a defined 2 mm margin.
What is the current status of trial NCT03094273?
This trial is currently completed. The enrollment target is 138 participants. The study started on 2013-02-25. Estimated completion is 2016-03.
What interventions are being tested in trial NCT03094273?
The interventions under investigation include: Saucerization biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT03094273?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04402788 · 138 participants · Phase 2
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial
- NCT04883255 · 138 participants · Early Phase 1
Cannabis Use, Cognition, and the Endocannabinoid System in HIV
- NCT05620784 · 138 participants · Phase 3
Intra-operative Loop Diuretics to Improve Same-day Discharge Rates After HoLEP
- NCT05832086 · 138 participants · Phase 2
Intermittent Fasting Using a Fasting-Mimicking Diet to Improve Prostate Cancer Control and Metabolic Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI